These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1628775)

  • 1. Studies on autoimmunity for T-cell-mediated beta-cell destruction. Distinct difference in beta-cell destruction between CD4+ and CD8+ T-cell clones derived from lymphocytes infiltrating the islets of NOD mice.
    Nagata M; Yoon JW
    Diabetes; 1992 Aug; 41(8):998-1008. PubMed ID: 1628775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of beta-cell antigens to CD4+ and CD8+ T cells of non-obese diabetic mice.
    Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1993 Aug; 151(3):1723-30. PubMed ID: 8101546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice.
    Nagata M; Santamaria P; Kawamura T; Utsugi T; Yoon JW
    J Immunol; 1994 Feb; 152(4):2042-50. PubMed ID: 7907110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of inflammatory infiltrate in activation and effector function of cloned islet reactive nonobese diabetic CD8+ T cells: involvement of a nitric oxide-dependent pathway.
    Gurlo T; Kawamura K; von Grafenstein H
    J Immunol; 1999 Dec; 163(11):5770-80. PubMed ID: 10570259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8 T cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone.
    Bradley BJ; Haskins K; La Rosa FG; Lafferty KJ
    Diabetes; 1992 Dec; 41(12):1603-8. PubMed ID: 1446802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
    Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
    PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
    Chosich N; Harrison LC
    Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of infiltrating T cells for impaired glucose metabolism in pancreatic islets isolated from non-obese diabetic mice.
    Strandell E; Sandler S; Boitard C; Eizirik DL
    Diabetologia; 1992 Oct; 35(10):924-31. PubMed ID: 1451948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice.
    Wang Y; Pontesilli O; Gill RG; La Rosa FG; Lafferty KJ
    Proc Natl Acad Sci U S A; 1991 Jan; 88(2):527-31. PubMed ID: 1899142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
    Rivereau AS; You S; Lalain S; Gouin E; Saï P
    Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
    Pankewycz O; Strom TB; Rubin-Kelley VE
    Eur J Immunol; 1991 Apr; 21(4):873-9. PubMed ID: 1902177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the pathogenesis of type I diabetes mellitus--destruction of pancreatic beta cells by cytotoxic T lymphocytes in nonobese diabetic mice].
    Nagata M
    Nihon Naibunpi Gakkai Zasshi; 1990 Mar; 66(3):145-58. PubMed ID: 2189754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor alpha-chain CDR3 sequences.
    Santamaria P; Utsugi T; Park BJ; Averill N; Kawazu S; Yoon JW
    J Immunol; 1995 Mar; 154(5):2494-503. PubMed ID: 7868915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destruction of pancreatic islet cells by cytotoxic T lymphocytes in nonobese diabetic mice.
    Nagata M; Yokono K; Hayakawa M; Kawase Y; Hatamori N; Ogawa W; Yonezawa K; Shii K; Baba S
    J Immunol; 1989 Aug; 143(4):1155-62. PubMed ID: 2663991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative and functional analyses of spleen and in situ islet immune cells before and after diabetes onset in the NOD mouse.
    Formby B; Hosszufalusi N; Chan E; Miller N; Teruya M; Takei S; Charles MA
    Autoimmunity; 1992; 12(2):95-102. PubMed ID: 1617115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
    Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
    Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of pancreas-infiltrating T cells in diabetic NOD mice: fusion with BW5147 yields a high frequency of islet-reactive hybridomas.
    Prud'homme GJ; Long TY; Bocarro DC; Balderas RS; Theofilopoulos AN
    Autoimmunity; 1991; 10(4):285-9. PubMed ID: 1837736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-independent cross-talk between macrophages and CD8+ T cells facilitates their cooperation during target destruction.
    Gurlo T; von Grafenstein H
    Int Immunol; 2003 Sep; 15(9):1063-71. PubMed ID: 12917258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.